Santiago Millan, Technical Lead, Global Platform for Access to Childhood Cancer Medicines at World Health Organization (WHO), shared on LinkedIn:
“Thank you The Lancet Oncology for featuring our comment on the need to transform childhood cancer medicines access through market shaping.
‘Together, we must seize the opportunity to build a broad coalition behind this agenda. Governments, manufacturers, procurement agencies, regulators, civil society organizations, people with lived experience, and academic institutions all have a role to play.
The Global Platform market shaping strategy makes it clear that we must deliver together to move beyond procuring and towards transforming markets. No child should die from a curable cancer because markets fail to function.’
(If you don’t currently have a subscription at thelancet.com, it can be accessed by registering for a free account-takes less than a minute to do so).
For more on the childhood cancer medicines market shaping strategy 2026-2030.”
Title: Why childhood cancer medicines need market shaping led by the Global Platform: toward market transformation
Authors: Santiago Millan, Tobias Kasper, Mary Atieno Ojoo, Hitesh Hurkchand, Andre M Ilbawi, Caroline N Kiyiika, Christopher Lim, Silvana Luciani, Bente Mikkelsen, Alessio Mola, Liliana Vasquez, Alarcos Cieza, Carlos Rodriguez-Galindo
Other posts featuring Santiago Millan on OncoDaily.
